Get the Stockscreener App
67.46
0.90%
0.60
After Hours:
68.25
0.79
+1.17%
Genedx Holdings Corp stock is traded at $67.46, with a volume of 579.23K.
It is up +0.90% in the last 24 hours and down -13.27% over the past month.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$66.86
Open:
$67.485
24h Volume:
579.23K
Relative Volume:
0.74
Market Cap:
$1.98B
Revenue:
$427.54M
Net Income/Loss:
$-21.02M
P/E Ratio:
-90.92
EPS:
-0.742
Net Cash Flow:
$14.26M
1W Performance:
+2.85%
1M Performance:
-13.27%
6M Performance:
-42.30%
1Y Performance:
-34.01%
1-Day Range:
$66.95
$72.39
1-Week Range:
$57.29
$72.39
52-Week Range:
$55.17
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
67.46 | 1.96B | 427.54M | -21.02M | 14.26M | -0.742 |
TMO
Thermo Fisher Scientific Inc
|
531.67 | 195.93B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
198.14 | 140.56B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
580.76 | 46.39B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
119.77 | 34.02B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
326.20 | 32.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
Jefferies reiterates GeneDx stock rating citing market penetration By Investing.com - Investing.com Australia
Why (WGS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Craig-Hallum reaffirms buy on GeneDx (WGS) with $153 price target - MSN
GeneDx Holdings Corp. (WGS) Latest Stock News & Headlines - Yahoo! Finance Canada
Dividend Watch: Does GeneDx Holdings Corp meet Warren Buffetts criteria2026 Retail & Daily Growth Stock Tips - baoquankhu1.vn
GeneDx Holdings Corp. (WGS) latest stock news and headlines - Yahoo Finance Singapore
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026 - marketscreener.com
GeneDx will release first-quarter results after market close May 4 - Stock Titan
Retail Trends: Can GeneDx Holdings Corp Equity Warrant weather a recession2026 Major Catalysts & Reliable Price Breakout Alerts - baoquankhu1.vn
Published on: 2026-04-12 04:15:28 - baoquankhu1.vn
Winners Losers: Can GeneDx Holdings Corp Equity Warrant continue delivering strong returnsPortfolio Risk Report & Verified Trade Idea Suggestions - baoquankhu1.vn
WGS Stock Chart | GENEDX HOLDINGS CORP (NASDAQ:WGS) - ChartMill
Cathie Wood's WGS Bet: Is the Genomics Dip the Main Character? - Bitget
Cathie Wood’s ARK sells BWX Technologies stock, buys GeneDx By Investing.com - Investing.com South Africa
Cathie Wood’s ARK sells BWX Technologies stock, buys GeneDx - Investing.com
Insider Trends: Can GeneDx Holdings Corp deliver alphaTrade Exit Report & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
GeneDx Stock Plunges 8.9% on Analyst Downgrades - National Today
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
Swing Trade: How does GeneDx Holdings Corp score in quality rankingsWeekly Profit Analysis & Reliable Momentum Entry Alerts - baoquankhu1.vn
Stock Recap: Is GeneDx Holdings Corp Equity Warrant stock showing strong momentum2026 Performance Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn
Are Institutional Outflows Quietly Rewriting GeneDx (WGS)’s Genomics‑and‑AI Investment Story? - Sahm
WGS | GeneDx Holdings Corp. Class News - Quiver Quantitative
GeneDx Holdings Corp. (WGS) stock price, news, quote and history - uk.finance.yahoo.com
WGSWW SEC FilingsGeneDx Holdings Corp 10-K, 10-Q, 8-K Forms - Stock Titan
GeneDx CEO Sells Over $2.9 Million in Shares - National Today
Understanding Momentum Shifts in (WGS) - Stock Traders Daily
Cathie Wood’s ARK sells Strata Critical Medical stock, buys GeneDx Holdings - Investing.com
Cathie Wood’s ARK sells Strata Critical Medical stock, buys GeneDx Holdings By Investing.com - Investing.com South Africa
WGS Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 46,933 Shares - MarketBeat
New Strong Buy Stocks for April 2nd - The Globe and Mail
Investment Review: Can GeneDx Holdings Corp deliver alphaWeekly Trend Report & AI Enhanced Trading Signals - baoquankhu1.vn
Book value per share of GeneDx Holdings Corp. – NASDAQ:WGS - TradingView
Down 25% in 4 Weeks, Here's Why GENEDX HOLDINGS (WGS) Looks Ripe for a Turnaround - Eastern Progress
GeneDx stock rating reiterated at Overweight by Piper Sandler - Investing.com Canada
SG Americas Securities LLC Boosts Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx holdings CFO Feeley sells $557k in shares By Investing.com - Investing.com Australia
GeneDx Holdings (WGS) Analyst Rating Update: Guggenheim Lowers P - GuruFocus
GeneDx holdings CFO Feeley sells $557k in shares - Investing.com
GeneDx (WGS) CFO exercises 16,250 RSUs, sells shares for taxes - Stock Titan
GeneDx (WGS) CEO exercises 80K RSUs, sells 47K shares for taxes - Stock Titan
GeneDx (NASDAQ:WGS) Stock Price Up 4.8%Still a Buy? - MarketBeat
WGSWW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Guggenheim Cuts GeneDx (NASDAQ:WGS) Price Target to $100.00 - MarketBeat
Decliners Report: Is GeneDx Holdings Corp stock forming a triangle pattern2026 Pullback Review & Weekly Top Performers Watchlists - baoquankhu1.vn
Momentum Shift: Is GeneDx Holdings Corp Equity Warrant stock showing strong momentum2026 Rallies & Smart Allocation Stock Reports - baoquankhu1.vn
Assessing GeneDx Holdings (WGS) Valuation After Recent Share Price Weakness - Yahoo Finance
Guidance Update: How does GeneDx Holdings Corp score in quality rankingsDip Buying & Weekly Return Optimization Alerts - baoquankhu1.vn
Moving Averages: How cyclical is GeneDx Holdings Corps revenue streamPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.41%
1.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):